Female Infertility. Female infertility
Conditions
Interventions
Intervention 1: Intervention group:Patients receive letrozole 2.5 mg daily for 5 days from the third day of the menstrual cycle. Intervention 2: Control group: People receive daily placebo for 5 days
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Women diagnosed with infertility IVF candidate women
Exclusion criteria
Exclusion criteria: pregnancy Presence of endometrial pathological lesions The person's lack of consent to participate in the study Intolerance of Letrozole in the patient Presence of Letrozole contraindications in patients such as liver diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assess endometrial thickness. Timepoint: The second or third day of the menstrual cycle. Method of measurement: sonography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Biochemical pregnancy. Timepoint: Once, 14 days after fetus transfer. Method of measurement: Blood sampling.;Clinical pregnancy. Timepoint: Once, 6 to 8 weeks after embryo transfer. Method of measurement: Observation of pregnancy sac and heart rate on ultrasound. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamideh Pakniat
Qazvin University of Medical Sciences
Outcome results
None listed